144 ·Filed Aug 6, 2026

BLCO

Bausch & Lomb Corp
NEUTRAL
Impact 2/10
Horizondays Processed1mo ago SEC0001959173-26-005713
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine post-vesting sale by a former director with no material signal. Monitor for any follow-on Form 4 filings to confirm execution, but no trading action is warranted based on this filing alone.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+20d ⚠ clustered
BLCO ▲ +10.95% at T+20d
NEUTRAL call ✓ call won +10.95% · α vs SPY +10.35% · entry $16.35 → $18.14
Next anchor: T+60d in 28d
Latest observation: T+38 +5.40% FF3 residual α
Entry anchored
Aug 6, 03:11 PM ET
via 1-min bar
T+1d
+2.63%
call +2.63% · α +2.02%
$16.78
settled 8w ago
T+5d
+3.85%
call +3.85% · α +2.64%
$16.98
settled 7w ago
T+20d
+10.95%
call +10.95% · α +10.35%
$18.14
settled 29d ago
T+60d
—
call — · α —
—
in 28d

Price Chart

Loading chart...

Executive Summary

Former director Andrew C. Von Eschenbach filed a Form 144 notice of intent to sell 12,500 BLCO common shares (~$206K at filing). The shares were acquired via restricted stock vesting on 04/23/2023 as compensation. This is a routine post-vesting sale by a former board member and carries minimal signal for the stock's near-term direction.

Key Facts

  • Former director Andrew C. Von Eschenbach filed Form 144 to sell 12,500 shares of BLCO common stock.
  • Estimated aggregate sale value is approximately $206,192.77.
  • Shares were acquired via restricted stock vesting on 04/23/2023 as compensation.
  • The sale is planned through Fidelity Brokerage Services LLC on or after 08/06/2026.

Financial Impact

Approximately $206K in planned insider sale by a former director — less than 0.003% of BLCO's $6.0B market cap.

dilution

Risk Factors

  • Insider selling is not material relative to market cap or trading volume.
  • No indication of broader insider sentiment shift from this single former-director filing.

Market Snapshot

Exchange
NYSE
Sector
Ophthalmic Goods
Analyst Consensus
56% bullish (18 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-005713
Document: 0001959173-26-005713-index.html0001959173-26-005713
Document: 0001959173-26-005713.txt0001959173-26-005713
16 reports for BLCO
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+20▲ +6.48%Jul 29, 2026
Filters
Rows
Reports for BLCO — sortable, filterable
TypeNow
Aug 14, 2026
7w ago
3 / CLUSTER
NEUTRAL ★ 2/10
$17.00 $17.23▲ +1.35%▲ +3.33%$17.11 (+0.65%)
Aug 14, 2026
7w ago
3
NEUTRAL ★ 2/10
$17.00 $17.23▲ +1.35%▲ +3.33%$17.11 (+0.65%)
Aug 14, 2026
7w ago
3
NEUTRAL ★ 2/10
$17.00 $17.23▲ +1.35%▲ +3.33%$17.11 (+0.65%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$16.98 $17.25▲ +1.59%▲ +3.34%$17.11 (+0.77%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$16.98 $17.25▲ +1.59%▲ +3.34%$17.11 (+0.77%)
Aug 7, 2026
8w ago
144
NEUTRAL ★ 2/10
$16.83 $17.73▲ +5.35%▲ +6.26%$17.11 (+1.66%)
Aug 6, 2026
8w ago
144
NEUTRAL ★ 2/10
$16.35 $18.14▲ +10.95%▲ +10.35%$17.11 (+4.65%)
Aug 6, 2026
8w ago
8-K
MIXED ★ 5/10
$16.35 $18.14▲ +10.95%▲ +10.35%$17.11 (+4.65%)
Jul 29, 2026
9w ago
8-K
BULLISH ★ 6/10
$16.20 $17.25▲ +6.48%▲ +1.46%$17.11 (+5.62%)
Feb 27, 2026
31w ago
Insider Cluster
BULLISH ★ 7/10
$18.30 $15.37▼ −16.01%▼ −8.45%$17.11 (−6.50%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (38h 38m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access